Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?

被引：1
|
作者：
Devlin, Shane M. [1 ]
机构：
[1] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2012年 / 18卷 / 06期
关键词：
ULCERATIVE-COLITIS; RISK-FACTOR; CANCER;
D O I：
10.1002/ibd.21869
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1184 / 1185
页数：2
相关论文
共 50 条
  • [41] Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop
    Axelrad, Jordan E.
    Cross, Raymond K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (03): : 429 - 431
  • [42] The Evolving Role of Thiopurines for Inflammatory Bowel Disease
    Rosen, Danya J.
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (01) : 234 - 240
  • [43] Optimising use of thiopurines in inflammatory bowel disease
    Raj, Lawrence Sunder
    Hawthorne, A. Barney
    FRONTLINE GASTROENTEROLOGY, 2010, 1 (01) : 44 - 51
  • [44] Stool DNA Methylation Markers for the Detection of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
    Kisiel, John B.
    Yab, Tracy C.
    Taylor, William R.
    Simonson, Julie A.
    Garrity-Park, Megan
    Hussain, Fareeda Taher Nazer
    Wolff, Bruce G.
    Sandborn, William J.
    Loftus, Edward V.
    Itzkowitz, Steven H.
    Rubin, David T.
    Zou, Hongzhi
    Mahoney, Douglas W.
    Ahlquist, David A.
    GASTROENTEROLOGY, 2012, 142 (05) : S26 - S27
  • [45] Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
    Shah, Shailja C.
    Glass, Jason
    Giustino, Gennaro
    ten Hove, Joren R.
    Castaneda, Daniel
    Torres, Joana
    Kumar, Akash
    Elman, Jordan
    Ullmann, Thomas A.
    Itzkowitz, Steven H.
    GUT AND LIVER, 2019, 13 (01) : 54 - +
  • [46] Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study
    Wu, Xian-Rui
    Zheng, Xiao-Bin
    Huang, Yan
    Cao, Qian
    Zhang, Hong-Jie
    Miao, Ying-Lei
    Zou, Kai-Fang
    Chen, Min
    Zhang, Fa-Ming
    Mei, Qiao
    Gonzalo, David
    Allende, Daniela
    Hu, Pin-Jin
    Shen, Bo
    Liu, Xiu-Li
    Lan, Ping
    GASTROENTEROLOGY REPORT, 2019, 7 (01): : 67 - 73
  • [47] Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia
    de Jong, Michiel E.
    Nagtegaal, Iris D.
    Vos, Shoko
    van der Post, Rachel S.
    van Herwaarden, Yasmijn
    Derikx, Lauranne A. A. P.
    Hoentjen, Frank
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (12) : 5647 - 5656
  • [48] Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
    Torres, J.
    de Chambrun, G. Pineton
    Itzkowitz, S.
    Sachar, D. B.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (05) : 497 - 508
  • [49] Optimizing the use of thiopurines in inflammatory bowel disease
    Goel, Rishi M.
    Blaker, Paul
    Mentzer, Alex
    Fong, Steven C. M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 138 - 146
  • [50] Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship
    Wijnands, Anouk M.
    Elias, Sjoerd G.
    Dekker, Evelien
    Fidder, Herma H.
    Hoentjen, Frank
    ten Hove, Joren R.
    Maljaars, P. W. Jeroen
    van der Meulen-de Jong, Andrea E.
    Mooiweer, Erik
    Ouwehand, Renske J.
    de Vries, Bas B. L. Penning
    Ponsioen, Cyriel Y.
    van Schaik, Fiona D. M.
    Oldenburg, Bas
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (07) : 612 - 620
12345